nifedipine has been researched along with Hepatitis in 3 studies
Nifedipine: A potent vasodilator agent with calcium antagonistic action. It is a useful anti-anginal agent that also lowers blood pressure.
Hepatitis: INFLAMMATION of the LIVER.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Here we present a case of nifedipine-induced hepatitis in a 78-year-old Caucasian female with no prior history of liver or autoimmune disease." | 7.88 | A case report of nifedipine-induced hepatitis with jaundice. ( Christy, J; Fishman, MJ; Ho, M; Li, D; Owen, D; Yusuf, D, 2018) |
| "Here we present a case of nifedipine-induced hepatitis in a 78-year-old Caucasian female with no prior history of liver or autoimmune disease." | 3.88 | A case report of nifedipine-induced hepatitis with jaundice. ( Christy, J; Fishman, MJ; Ho, M; Li, D; Owen, D; Yusuf, D, 2018) |
| "Fourteen normotensive patients with liver disease (6 with cirrhosis and 8 with chronic hepatitis) and 7 healthy volunteers were given a single oral dose of nilvadipine 2 mg." | 3.68 | Elevated plasma nilvadipine concentration after single and chronic oral administration to patients with chronic liver disease. ( Fujishima, M; Ito, Y; Kikuchi, M; Kobayashi, K; Takata, Y; Tsukashima, A; Ueno, M; Yoshizumi, T, 1992) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (33.33) | 18.2507 |
| 2000's | 1 (33.33) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Yusuf, D | 1 |
| Christy, J | 1 |
| Owen, D | 1 |
| Ho, M | 1 |
| Li, D | 2 |
| Fishman, MJ | 1 |
| Wang, X | 1 |
| Zhao, X | 1 |
| Lou, YQ | 1 |
| Lin, ZB | 1 |
| Zhang, GL | 1 |
| Takata, Y | 1 |
| Yoshizumi, T | 1 |
| Ito, Y | 1 |
| Kikuchi, M | 1 |
| Ueno, M | 1 |
| Tsukashima, A | 1 |
| Kobayashi, K | 1 |
| Fujishima, M | 1 |
3 other studies available for nifedipine and Hepatitis
| Article | Year |
|---|---|
A case report of nifedipine-induced hepatitis with jaundice.
Topics: Aged; Calcium Channel Blockers; Chemical and Drug Induced Liver Injury; Female; Hepatitis; Humans; J | 2018 |
Effects of Ganoderma lucidum polysaccharide on CYP2E1, CYP1A2 and CYP3A activities in BCG-immune hepatic injury in rats.
Topics: Adjuvants, Immunologic; Animals; BCG Vaccine; Chlorzoxazone; Chromatography, High Pressure Liquid; C | 2007 |
Elevated plasma nilvadipine concentration after single and chronic oral administration to patients with chronic liver disease.
Topics: Administration, Oral; Calcium Channel Blockers; Chronic Disease; Hemodynamics; Hepatitis; Humans; Li | 1992 |